Company Overview - Jiet Bio is located in Guangzhou Economic and Technological Development Zone, established on April 11, 2001, and listed on January 22, 2020 [1] - The company specializes in cell culture and related products, classified under the pharmaceutical and biological industry, specifically in medical devices and consumables [1] Stock Performance - As of August 22, Jiet Bio's stock price decreased by 2.01%, trading at 19.46 CNY per share, with a total market capitalization of 2.731 billion CNY [1] - Year-to-date, the stock has increased by 52.53%, but has seen a decline of 3.42% over the last five trading days [1] - The stock has experienced a 0.83% increase over the last 20 days and a 23.73% increase over the last 60 days [1] Financial Performance - For the period from January to March 2025, Jiet Bio reported a revenue of 124 million CNY, reflecting a year-on-year growth of 26% [1] - The company has distributed a total of 152 million CNY in dividends since its A-share listing, with 30.06 million CNY distributed over the last three years [1] Shareholder Information - As of March 31, 2025, Jiet Bio had 7,864 shareholders, an increase of 3.79% from the previous period, with an average of 17,837 circulating shares per shareholder, a decrease of 3.65% [1] - Among the top ten circulating shareholders, the Jia Shi Leading Advantage Mixed A fund holds 1.6695 million shares, unchanged from the previous period [2]

Core Viewpoint - The company announces the resignation of its board secretary, Ge Jingbo, due to personal reasons, and he will no longer hold any position within the company [2][3]. Group 1: Resignation Details - Ge Jingbo submitted a written resignation report to the board, which is effective upon delivery to the board [3]. - The company confirms that Ge Jingbo has completed the handover of his responsibilities, and his resignation will not affect the normal operations of the company [3]. Group 2: Impact on the Company - The company will promptly complete the selection of a new board secretary in accordance with relevant regulations and its articles of association [3]. - Until a new board secretary is appointed, the chairman, Yuan Jianhua, will act in this capacity [3]. - Ge Jingbo did not hold any shares in the company during his tenure and was recognized for his diligent work in governance, information disclosure, and investor relations [3].

证券日报网讯8月19日晚间，洁特生物发布公告称，董事会于近日收到公司董事会秘书葛井波先生的书 面辞职报告。葛井波先生因个人原因申请辞去公司董事会秘书一职，辞职后将不再担任公司任何职务。 ...

Group 1 - The company Jiet Biotech announced the resignation of its board secretary, Ge Jingbo, due to personal reasons, and he will no longer hold any position within the company after his resignation [2] - For the fiscal year 2024, Jiet Biotech's revenue composition is as follows: consumables account for 95.02% of total revenue, while other business segments contribute 4.98% [2]

广州洁特生物过滤股份有限公司（以下简称"公司"）董事会于近日收到公 司董事会秘书葛井波先生的书面辞职报告。葛井波先生因个人原因申请辞去公司 董事会秘书一职，辞职后将不再担任公司任何职务。根据《中华人民共和国公司 法》等法律法规及《公司章程》的有关规定，辞职报告自送达董事会之日起生效。 具体情况如下： | 姓名 | | 离任职务 | | 离任时间 | | | 原定任期到 | | | 是否继续在上 | 是否存在未 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | | | 期日 | | 离任原因 | 市公司及其控 股子公司任职 | 履行完毕的 公开承诺 | | 葛井波 | 董 | 事 | 会 秘 | 2025 8 | 年 | 月 | 2026 年 9 | 月 | 个人原因 | 否 | 否 | | | 书 | | | 19 日 | | | 14 日 | | | | | | 证券代码：688026 | 证券简称：洁特生物 | 公告编号：2025-049 | | --- | --- | --- | ...

Group 1 - The company, JieTe Bio (688026), announced the resignation of its board secretary, Ge Jingbo, due to personal reasons [1] - Following the resignation, the company’s chairman, Yuan Jianhua, will temporarily assume the responsibilities of the board secretary until a new appointment is made [1]

通过天眼查大数据分析，广州洁特生物过滤股份有限公司共对外投资了14家企业，参与招投标项目182 次，知识产权方面有商标信息79条，专利信息266条，此外企业还拥有行政许可67个。 来源：金融界 金融界消息 截至2025年8月14日收盘，洁特生物（688026）报收于19.77元，下跌5.86%，换手率 5.92%，成交量8.30万手，成交金额1.68亿元。 资金流向方面，今日主力资金净流出3352.19万元，占比成交额19.96%。其中，超大单净流出1010.96万 元、占成交额6.02%，大单净流出2341.23万元、占成交额13.94%，中单净流出流入842.18万元、占成交 额5.02%，小单净流入2510.02万元、占成交额14.95%。 洁特生物最新一期业绩显示，截至2025一季报，公司营业总收入1.24亿元、同比增长26.00%，归属净利 润1646.23万元，同比增长101.29%，扣非净利润1564.92万元，同比增长269.23%，流动比率8.034、速动 比率6.628、资产负债率28.76%。 天眼查商业履历信息显示，广州洁特生物过滤股份有限公司，成立于2001年，位于广州市，是一家以从 ...

Core Viewpoint - The company has decided not to adjust the conversion price of its convertible bonds, despite triggering the downward adjustment clause due to stock price performance [2][7]. Group 1: Convertible Bond Details - The company issued 4.4 million convertible bonds at a face value of 100 RMB each, raising a total of 440 million RMB [3]. - The initial conversion price was set at 48.23 RMB per share, which was adjusted to 48.09 RMB on June 6, 2023, and further adjusted to 48.02 RMB on July 4, 2024, and to 47.95 RMB on July 2, 2025 [4]. - The downward adjustment clause is triggered when the stock price is below 85% of the conversion price for at least 15 out of 30 consecutive trading days [5]. Group 2: Board Decision - The board of directors convened on August 1, 2025, and unanimously agreed not to adjust the conversion price, with all related directors abstaining from the vote [8][9]. - The decision will remain in effect for three months, until November 1, 2025, during which time the company will not propose any downward adjustment even if the clause is triggered again [7][9].

Group 1 - The company held its 22nd meeting of the 4th Board of Directors on August 1, 2025, with all 7 participating directors voting unanimously [1] - The Board approved the proposal not to lower the conversion price of the "Jietai Convertible Bonds," with 4 votes in favor and no opposition or abstentions [1] - Related directors recused themselves from the voting process [1] Group 2 - The company will not propose a downward adjustment to the conversion price within the next three months, from now until November 1, 2025 [2] - If the conversion price adjustment clause is triggered again after November 2, 2025, the Board will reconvene to decide on the adjustment [2] - Further details are available in the announcement published on the Shanghai Stock Exchange website [2]

Core Viewpoint - The company, JieTe Bio, announced that its board of directors has approved a proposal not to lower the conversion price of its convertible bonds, known as "JieTe Convertible Bonds" [2] Group 1 - The fourth meeting of the fourth board of directors took place on August 1, where the proposal was reviewed and approved [2]